Home > Boards > US Listed > Medical - Healthcare >

Hoth Therapeutics (HOTH)

Add HOTH Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/14/2022 2:05:09 PM - Followers: 27 - Board type: Free - Posts Today: 0




HaloVax, LLC is a biopharmaceutical company and joint venture entity of Voltron Therapeutics, Inc. and Hoth Therapeutics, Inc.
The joint venture was announced on March 23, 2020 (click here) and plans to advance an application of VaxCelerate,
a self-assembling vaccine (SAV) platform licensed from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH),
to develop a vaccine designed to protect patients at risk of Coronavirus (COVID-19) infection. Voltron Therapeutics, Inc. has acquired an exclusive license to this technology.

HaloVax and Hoth, with the support of MGH, will work jointly on bringing this SAV to patients at risk of being infected with COVID-19.
The VaxCelerate platform was developed to improve patient outcomes by engaging the immune system to identify and remove infectious agents.
The technology initially demonstrated proof of concept in Lassa Fever, an emerging infectious disease, with the support of the Department of Defense (DoD).
These same principles are being applied to developing a vaccine against the COVID-19 pandemic.

VaxCelerate offers two unique elements to combat the Coronavirus – one fixed immune adjuvant and one variable immune targeting.
VaxCelerate offers several potential advantages over other compounds in combination therapy. In infectious applications, it allows rapid development against viruses and other pathogens.
The vaccine focuses on both DNA and internal / external mutated proteins providing the immune system with more potential targets to attack.

VaxCelerate was created by Drs. Mark Poznansky, MD, PhD, and Jeffrey Gelfand, MD,
who will continue to support its research and development, as COVID-19 has reached pandemic status. Dr. Poznansky is the Director of the Vaccine and Immunotherapy Center (VIC)
and Physician at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. Dr. Poznansky will serve as both scientific founder and scientific
advisory board member to help advise on the early clinical research and implementation of testing in the hospital setting as well as to help gather additional academic and clinical KOLs to serve on the SAB.


Our goal: Generate a safe and effective vaccine with animal data in 6 months or less.

HaloVax is a pre-clinical biotech company focused on bringing our Self-Assembling Vaccine (SAV) to patients at risk for COVID-19 infection.
We believe that our vaccine could be particularly effective and improve patient outcomes by engaging the immune system to identify and attack this pandemic infectious agent.

This technology has initially demonstrated proof of concept in Lassa Fever, an emerging infectious disease.
This was done with the support of the DoD.
These same principles are being applied to developing a vaccine against the pandemic coronavirus, known as COVID-19

The SAV program has intellectual property surrounding composition of matter.
Incorporating HSP70 more broadly activates the immune system in contrast to prior vaccine efforts which used classic adjuvants like alum, etc.
The vaccine is >90% HSP70 and Aviden. Neoantigens are then incorporated to customize the vaccine.

We believe that the VaxCelerate technology has the potential to provide a differentiated approach to a COVID-19 vaccine.

Shs Outstand 10.25M
Shs Float 8.33M
Short Float 3.18%
Debt/Eq   no debt 0.00







 *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HOTH News: Quarterly Report (10-q) 05/12/2022 12:45:54 PM
HOTH News: Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort 05/03/2022 04:09:00 AM
HOTH News: Current Report Filing (8-k) 04/29/2022 12:25:00 PM
HOTH News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/27/2022 03:06:02 AM
HOTH News: Proxy Statement (definitive) (def 14a) 04/27/2022 03:01:44 AM
#221   offering has been closed... .70 break incoming! otcburner 04/14/22 02:05:09 PM
#220   The last recent rise and fall was due ShortSale4U 04/13/22 11:52:10 PM
#219   Agreed. Worthless. mplscubfan 04/12/22 08:25:22 AM
#218   Junk in my honest opinion logsplitter 04/12/22 08:23:20 AM
#217   Well the offer is at the current market ShortSale4U 04/12/22 06:16:09 AM
#216   Lol that's a base for meth and coke hawkshaw812 04/12/22 02:17:04 AM
#215   Has potential . That is evident with the ShortSale4U 04/11/22 05:17:53 PM
#214   Yet MORE Petri-Dish-&-Test-Tube (so-called) science Just-Keep-Trying 04/11/22 03:07:30 PM
#213   HOTH was --- and still is --- a Just-Keep-Trying 04/11/22 02:59:00 PM
#212   CONGRAT$ G2G 04/11/22 12:11:16 PM
#211   Insane volume, traders pushing this up, then down, ok2buy 04/11/22 11:37:30 AM
#210   This will explode today,,,, the number of people Runners123 04/11/22 11:09:56 AM
#208   HOTH:Vey HOT p/m Sibware 04/11/22 09:20:15 AM
#207   HOTH > trading float > 23M crudeoil24 04/11/22 08:26:15 AM
#206   Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-KIT, Proves Effective crudeoil24 04/11/22 08:22:57 AM
#205   Damn Awl416 04/11/22 08:10:52 AM
#204   co dumping tigertiger88 03/11/22 10:20:28 AM
#203   More good news took it to $.95 today Runners123 03/10/22 04:16:09 PM
#202   *** HOTH *** $.62 alzheimers pretrial drug , Runners123 03/04/22 10:54:44 AM
#201   Pm volume Awl416 01/04/22 08:03:34 AM
#200   https://www.benzinga.com/general/biotech/21/12/24696438/hoth-therapeutics-report Pennybuster 12/20/21 06:35:05 PM
#199   Now im hoping they get over a dollar Pennybuster 12/12/21 03:30:09 PM
#198   another part of me thinks HOTH will rise Nebuchadnezzar 10/07/21 06:27:08 PM
#197   It could be. Pennybuster 10/07/21 06:23:44 PM
#196   19M share float, insiders own 16% Nebuchadnezzar 10/07/21 06:18:11 PM
#195   Yep It has sucked. Pennybuster 10/07/21 06:11:47 PM
#194   HOTH has officially tried my patience. Nebuchadnezzar 10/07/21 06:11:20 PM
#193   HOTH is beginning to IRK Nebuchadnezzar 09/22/21 11:27:39 PM
#192   Yes sir. :) Pennybuster 09/09/21 09:07:02 AM
#191   HOTH- Inverted H&S? Nebuchadnezzar 09/09/21 12:58:06 AM
#190   Hoth Therapeutics Announces Positive Phase 1b Results for Pennybuster 09/08/21 09:19:06 AM
#189   Right now we are sitting on the 50 Pennybuster 09/07/21 09:06:17 PM
#188   my first entry was the $1.60s, have kept Nebuchadnezzar 09/07/21 07:25:25 PM
#187   I picked up some more today but at Pennybuster 09/07/21 07:21:52 PM
#186   picked up some $1.32s and $1.33s today as Nebuchadnezzar 09/07/21 07:18:51 PM
#185   Continuing to add. Pennybuster 09/02/21 08:36:20 PM
#184   HOTH-- Nebuchadnezzar 08/31/21 04:24:33 PM
#183   HOTH up 11% premarket Nebuchadnezzar 08/26/21 09:24:56 AM
#182   Good morning Neb, HOTH $1.27 I yankee2 08/26/21 02:34:10 AM
#181   been adding Nebuchadnezzar 08/25/21 11:27:02 PM
#180   i think this one will bounce again soon, Nebuchadnezzar 08/08/21 12:04:51 PM
#179   HOTH- time to add again Nebuchadnezzar 07/28/21 01:46:07 PM
#178   HOTH Holding All here also Neb! yankee2 06/30/21 06:24:27 AM
#177   still holding my $1.30s-$1.60s Nebuchadnezzar 06/30/21 01:31:38 AM
#176   GM Neb HOTH $1.75 I was yankee2 06/08/21 02:39:19 AM
#175   Nice close. Tomorrow we shall see another jump Lilarmojohn 06/07/21 04:30:55 PM
#174   HOTH just blew up! chart was telling a story Nebuchadnezzar 06/07/21 02:39:14 PM
#173   Some nice biopharma moves today! crudeoil24 06/07/21 01:51:13 PM
#172   highest volume in well over a month +rounded bottom Nebuchadnezzar 06/07/21 01:50:06 PM
Consent Preferences